Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with epstein-barr virus and anatomic location in the body of the stomach
- 1 January 2000
- journal article
- Published by Elsevier in Human Pathology
- Vol. 31 (1) , 45-50
- https://doi.org/10.1016/s0046-8177(00)80197-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Overexpression of mutant p53 and c‐erbB‐2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: With respect to histological subtypes and stagesJournal of Gastroenterology and Hepatology, 1998
- Alterations of p16INK4A and p15INK4B genes in gastric carcinomasCancer, 1997
- Frequent detection of aberrant RNA transcripts of theCDKN2 gene in human gastric adenocarcinomaInternational Journal of Cancer, 1997
- Epstein-barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulationHuman Pathology, 1996
- Allelic imbalance in gastric cancer: An affected site on chromosome arm 3pGenes, Chromosomes and Cancer, 1995
- Loss of Heterozygosity on the Short Arm of Chromosome 9 without p16 Gene Mutation in Gastric CarcinomasJapanese Journal of Cancer Research, 1995
- Helicobacter pylori in hispanics: Comparison with blacks and whites of similar age and socioeconomic classGastroenterology, 1992
- Helicobacter pyloriInfection and Gastric Carcinoma among Japanese Americans in HawaiiNew England Journal of Medicine, 1991
- Helicobacter pyloriInfection and the Risk of Gastric CarcinomaNew England Journal of Medicine, 1991
- THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMAActa Pathologica Microbiologica Scandinavica, 1965